Osaka, Japan

Minoru Ikeda

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Minoru Ikeda: Innovator in Visceral Obesity Research

Introduction

Minoru Ikeda is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the area of visceral obesity. With a total of 3 patents to his name, Ikeda's work focuses on innovative methods for diagnosing and treating metabolic diseases associated with visceral obesity.

Latest Patents

Ikeda's latest patents include a test agent for visceral obesity and its applications. This invention discloses a method for detecting visceral obesity in a subject, along with a test agent that is useful for this method. The patent also outlines a method for searching for substances that can serve as active ingredients to ameliorate visceral obesity. The test agent comprises a polynucleotide with at least 15 nucleotides that can hybridize with the nucleotide sequence for the coiled-coil domain containing protein 3 (CCDC3) gene. Additionally, it includes an antibody capable of recognizing the CCDC3 protein.

Career Highlights

Throughout his career, Minoru Ikeda has worked with reputable organizations such as Shionogi Company Limited and Shiga University of Medical Science. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ikeda has collaborated with notable colleagues, including Kohji Hanasaki and Takashi Ono. These partnerships have further enriched his research endeavors and have led to significant advancements in the field.

Conclusion

Minoru Ikeda's innovative work in the realm of visceral obesity has the potential to impact the medical field significantly. His patents reflect a commitment to improving health outcomes through scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…